✦ LIBER ✦

Vinblastine VS. nitrogen mustard therapy of Hodgkin's disease

✍ Scribed by Ediz Z. Ezdinli; Leon Stutzman

Publisher: John Wiley and Sons
Year: 1968
Tongue: English
Weight: 591 KB
Volume: 22
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(196808)22:2<473::aid-cncr2820220227>3.0.co;2-i

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison of nitrogen mustard, vincri

A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (mopp) vs. nitrogen mustard in advanced hodgkin's disease

✍ Charles M. Huguley Jr; John R. Durant; Russell R. Moores; Yick-Kwong Chan; Ronal 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 1016 KB

Long-term remission in hodgkin's disease

Long-term remission in hodgkin's disease after nitrogen mustard therapy. Report of a Case

✍ Joseph M. Kiely; Edgar G. Harrison JR. 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 762 KB

A patient with Hodgkin's disease (Stage IIB) was given nitrogen mustard shortly after diagnosis and has survived, without recurrence, for more than 5 years. HFhfOTHERAPY FOR CANCER IS OFTEN OF C palliative benefit but is only rarely curative. Single-agent chemotherapy4, 5 , 9 has achieved cure rate

Vinblastine in the treatment of advanced

Vinblastine in the treatment of advanced Hodgkin's disease

✍ Dr. W. Davies Sohier Jr.; Rose K. L. Wong; Alan C. Aisenberg 📂 Article 📅 1968 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 3 views

In 35 cases of advanced Hodgkin's disease (stage IIIB to IVB), of whom 33 were no longer responsive to the alkylating agents, vinblastine produced clinically useful remissions in 22 patients or 64%. Complete objective responses were unusual but one third of these cases experienced partial remissions

Therapy of IIIA Hodgkin's disease

✍ Leonard R. Prosnitz 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Chromosomal damage in sperm of patients

Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy

✍ B. F. Brandriff; M. L. Meistrich; L. A. Gordon; A. V. Carrano; J. C. Liang 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 607 KB

ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY

ACUTE MYELOID LEUKEMIA FOLLOWING THERAPY OF HODGKIN'S DISEASE WITH RADIOTHERAPY AND ABVD (DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE)

✍ J. H. LIPTON; M. GOSPODAROWICZ; S. REINGOLD 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

A 26-year-old man developed myelodysplasia rapidly progressing to acute myelomonocytic leukemia 3 years after receiving three cycles of ABVD chemotherapy and upper mantle and upper abdomen radiotherapy for stage IA Hodgkin's disease. This represents the fourth such case reported. The risk of seconda